Tech Company Financing Transactions
CardiAQ Valve Technologies Funding Round
On 11/29/2012, CardiAQ Valve Technologies raised $37.3 million in Series B funding from OrbiMed, Synthesis Capital and Versant Ventures.
Transaction Overview
Company Name
Announced On
11/29/2012
Transaction Type
Venture Equity
Amount
$37,300,000
Round
Series B
Investors
Proceeds Purpose
The funding, which incorporates conversion of a 2011 bridge financing, will be used to further validate the Company's TMVI technology and is expected to carry the Company through its feasibility and CE mark clinical trials.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2 Jenner 100
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
CardiAQ Valve Technologies develops innovative approaches to heart valve replacement, focused on transcatheter mitral valve implantation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Arshad Quadri
Chief Executive Officer
Rob Michiels
Chief Medical Officer
Arshad Quadri
Chief Operating Officer
Brent Ratz
Browse more venture capital transactions:
Prev: 11/29/2012: Triggit venture capital transaction
Next: 11/29/2012: BAM Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs